title: Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.
abstract: Deregulated steroids are involved in different hormone-dependent tumors, including benign and malignant uterine neoplasms. Leiomyomas (LM) are estrogen and progesterone-dependent benign tumors, whereas "bizarre or atypical LMs" (AL) are considered a subgroup of LM and clinically benign, although their malignant potential is suspect. Uterine leiomyosarcomas (LMS) are malignant smooth muscle tumors, and ovarian steroids may control their growth. Estrogen effects are mediated by 2 receptors, estrogen receptors (ER) α and β, and the ratio of both receptors seems to be a critical parameter in the estrogen-mediated carcinogenic process. Estradiol induces the expression of neurotensin (NTS), and the coupling of this peptide with its high-affinity receptor, NTS1, has been involved in the regulation of tumoral cell growth. Given the importance of these markers in tumor development, we aim to determine the status of ERα and ERβ in the myometrium and LM, AL, and LMS, concomitantly with the expression of NTS/NTS receptor 1 in these tumors. For that purpose, we use immunohistochemistry for all markers analyzed and in-situ hybridization to detect NTS mRNA. These data suggest that LMS are estrogen-dependent tumors, which may use NTS as an autocrine growth factor. In addition, the phenotype of AL with regard to ERα and ERβ status and NTS expression is closer to LMS than LM; thus, a potential malignization of this tumor is feasible.
authors.affiliation: Departamento de Microbiología y Biología Celular, Àrea de Biología Celular, Facultad de Biología, Universidad de La Laguna, La Laguna, Tenerife, Spain.
authors.forename: Yurena
authors.initials: Y
authors.lastname: Rodríguez
authors.forename: Delia
authors.initials: D
authors.lastname: Báez
authors.forename: Francisco Montes
authors.initials: FM
authors.lastname: de Oca
authors.forename: Candelaria
authors.initials: C
authors.lastname: García
authors.forename: Idaira
authors.initials: I
authors.lastname: Dorta
authors.forename: Ricardo
authors.initials: R
authors.lastname: Reyes
authors.forename: Francisco
authors.initials: F
authors.lastname: Valladares
authors.forename: Teresa A
authors.initials: TA
authors.lastname: Almeida
authors.forename: Aixa R
authors.initials: AR
authors.lastname: Bello
mesh_terms: D002467:Cell Nucleus / Q000737:chemistry; D047628:Estrogen Receptor alpha / Q000032:analysis*; D047629:Estrogen Receptor beta / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007889:Leiomyoma / Q000737:chemistry*; D007890:Leiomyosarcoma / Q000737:chemistry*; D009130:Muscle, Smooth / Q000737:chemistry / Q000648:ultrastructure; D009215:Myometrium / Q000737:chemistry; D009496:Neurotensin / Q000032:analysis*; D018028:Receptors, Neurotensin / Q000032:analysis; D014594:Uterine Neoplasms / Q000737:chemistry*
chemical_list: D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D018028:Receptors, Neurotensin; C114036:neurotensin type 1 receptor; D009496:Neurotensin